A Study of the Effectiveness and Safety of Risperidone Versus Placebo as add-on Therapy to Mood Stabilizers, in the Treatment of Manic Episodes Associated With Bipolar Disorder.
Clinical trial NCT00250367 · COMPLETED
Trial details
- NCT number
- NCT00250367
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1997-10-01
- Enrollment
- 151
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.